Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

Share Price is delayed by 15 minutes
Get Live Data
39.00    1.00 (2.63%)
Bid:
38.00
Ask:
40.00
Spread: 2.00 (5.263%)
Market Cap: £17.09m
MANO Live PriceLast checked at - London Stock Exchange

Intraday Manolete Partn. Share Chart

Further Trading Update

20 Apr 2023 07:00

RNS Number : 8857W
Manolete Partners PLC
20 April 2023
 

20 April 2023

 

 

Manolete Partners PLC

("Manolete" or the "Company")

 

Further Trading Update

Manolete Partners plc (AIM:MANO), the leading quoted UK insolvency litigation financing company, is pleased to provide the following additional update on trading for the year ending 31 March 2023 ("FY23").

 

This announcement follows on from our recent Trading Update dated 14 March 2023.

 

All figures contained in this announcement are subject to full audit.

 

1. Record New Case Investments

 

The final number of new case investments for FY23 was 263, 65% higher than the 159 new case investments for FY22. The FY23 number is the highest Manolete has ever recorded.

 

For H1 FY23, new case investments were only 6% higher than H1 FY22. For H2 FY23, new case investments were 122% higher than H1 FY22, as the UK insolvency market returned to more normal operating conditions following a two-year suppression of the market by the UK Government in response to the Covid-19 pandemic.

 

2. Record New Case Enquiries

 

For the full FY23, new case enquiries increased by 48% to a record high of 798 (FY22: 540), again driven by a particularly strong rise of 60% in H2 FY23 compared to H2 FY22.

 

3. Record Case Completions

 

In FY23 Manolete completed a record number of cases: 192 (FY22: 139 completed cases) representing an aggregate of £33.7m (FY22: £15.3m) legally binding settlements, together with a small number of favourable judgments. This record level of completed cases will drive cash income for the foreseeable future, as the Company collects in the cash owed by defendants on these matters.

 

4. Record Gross Cash Recoveries

 

In FY23, Manolete delivered record gross cash recoveries from previously completed cases of £26.7m, 72% higher than the £15.5m for FY22. The £26.7m is spread across 237 separate completed cases (FY22: 183) at an average of £113k per case (FY22: £85k).

 

For FY23, after all costs (including new case investments, taxation, dividends and interest), the Company generated £1.9m of net free cashflow compared to a net outflow of £4.4m for FY22.

 

5. Profit Estimate

 

Whilst subject to full audit, after a PBT loss of £(5.5)m for H1 FY23, the Company expects to report a PBT profit of £1.6m for H2 FY23. Consequently, the Board expects the PBT loss for the full year ended 31 March 2023 to be £(3.9)m.

 

Steven Cooklin, CEO, commented: "Having navigated through a very testing last two years due to the unique challenges of Covid-19, we are pleased to see the business drive back into profitability in the second half of FY23, driven by record numbers of new case enquiries, new case investments and case completions. Organic cash generation from previously completed cases also hit a record level in FY23 with gross cash of £26.7m and our best ever net cash generation. With the UK economy facing challenging macro headwinds, particularly high inflation and high interest rates, we expect our market to remain strongly buoyant for the foreseeable future."

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 ("MAR").

 

For further information please contact:

 

Manolete Partners

Steven Cooklin (Chief Executive Officer) via Instinctif Partners

 

Peel Hunt (NOMAD and Sole Broker) +44 (0)20 7418 8900

Paul Shackleton

 

Instinctif Partners +44 (0)20 7457 2020

Tim Linacre

Victoria Hayns

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEASLEAFNDEEA
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Six Monthly Return
20th May 202612:00 pmRNSDirectorate Change
28th Apr 20263:19 pmRNSHolding(s) in Company
24th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSDirectorate Changes
22nd Dec 20257:00 amRNSGrant of Share Options
22nd Dec 20257:00 amRNSGrant of Share Options
17th Dec 20253:13 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSBlock Listing Six Monthly Return
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20254:10 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSHalf-year results
4th Nov 20257:00 amRNSNotice of Interim Results
16th Sep 20252:41 pmRNSResult of AGM
16th Sep 20257:00 amRNSAGM Update
22nd Aug 20257:00 amRNSDirectorate Change
20th Aug 202512:11 pmRNSPosting of Annual Report and Notice of AGM
11th Aug 20257:00 amRNSBoard Changes
5th Aug 202510:18 amRNSHolding(s) in Company
5th Aug 202510:17 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
28th Jul 20258:30 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSTruck Cartel Case Settlement
14th Jul 20257:00 amRNS-RMelloMonday Investor Webinar
9th Jul 20251:45 pmRNSHolding(s) in Company
26th Jun 20257:00 amRNSFull Year Results
25th Jun 20257:00 amRNS-RManolete ranked in Band 1 by Chambers
19th Jun 20252:45 pmRNSHolding(s) in Company
19th Jun 20251:54 pmRNSNotice of Results
30th May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20257:00 amRNSTrading Update
7th Apr 202512:41 pmRNSDirectorate Change
28th Mar 20257:00 amRNSNew Revolving Credit Facility with HSBC Bank
4th Feb 20257:00 amRNSUpdate on Cartel Claims
29th Nov 20247:00 amRNSBlock Listing Six Monthly Return
19th Nov 20247:00 amRNSHalf-year Report
24th Oct 20241:49 pmRNSNotice of Results
17th Oct 202412:35 pmRNSDirector/PDMR Shareholding
30th Sep 202411:49 amRNSResult of AGM
20th Sep 20247:00 amRNSGrant of Share Options
6th Sep 20241:41 pmRNSPosting of Annual Report and Notice of AGM
3rd Sep 20247:00 amRNSAudited results for the year ended 31 March 2024
29th Aug 20247:00 amRNSRetail Investor Presentation
25th Jul 20245:09 pmRNSPCA Shareholding
27th Jun 20247:00 amRNSNotice of Results
31st May 20247:00 amRNSBlock Listing Six Monthly Return
8th May 20247:00 amRNSAppointment of New External Audit Firm
2nd May 20247:00 amRNSChange of Auditor
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.